This company has been marked as potentially delisted and may not be actively trading. Idera Pharmaceuticals (IDRA) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock IDRA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Energy Recovery Wins “Breakthrough Innovation Award†at IDRA World CongressDecember 16, 2024 | businesswire.comEkso Bionics (NASDAQ: EKSO)April 11, 2024 | fool.comKiniksa PharmaceuticalsNovember 15, 2023 | forbes.comNabriva Therapeutics AG (NBRVF)August 9, 2023 | investing.comMarginaliaApril 26, 2023 | npr.orgA mysterious rift propels the story in ‘Take What You Need’March 17, 2023 | washingtonpost.comIdera Pharmaceuticals, Inc.: Idera Pharmaceuticals Announces Name Change to Aceragen, Inc. and Provides Near-Term Strategic OutlookJanuary 18, 2023 | finanznachrichten.deIdera Pharmaceuticals Announces Name Change to Aceragen, Inc. and Provides Near-Term Strategic OutlookJanuary 17, 2023 | finance.yahoo.comWhy Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionJanuary 10, 2023 | msn.comIdera (IDRA) Stock Soars on GlaxoSmithKline PartnershipJanuary 4, 2023 | thestreet.comIdera Pharmaceuticals, Inc.: Idera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 18, 2022 | finanznachrichten.deIdera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 14, 2022 | finance.yahoo.comIdera Pharma Acquires Rare Disease Player, Names New CEOSeptember 29, 2022 | finance.yahoo.comIdera Pharma Shares Rise Nearly 18% After Aceragen AcquisitionSeptember 28, 2022 | marketwatch.comIdera Pharmaceuticals Acquires AceragenSeptember 28, 2022 | finance.yahoo.comIdera Pharmaceuticals Stock (NASDAQ:IDRA), DividendsSeptember 27, 2022 | benzinga.comIdera Pharmaceuticals Reports Second Quarter 2022 Financial ResultsAugust 9, 2022 | finance.yahoo.comIdera halts melanoma trial for cancer candidate after early positive resultsMay 17, 2022 | seekingalpha.comWhy Are Idera Pharmaceuticals Shares Soaring TodayMay 17, 2022 | finance.yahoo.comIdera Pharmaceuticals Shares Positive Results from Investigator-Sponsored Trial in Melanoma Patients at Amsterdam UMCMay 17, 2022 | finance.yahoo.comIdera Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate UpdateMay 5, 2022 | finance.yahoo.comIdera Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate UpdateMarch 31, 2022 | finance.yahoo.comIdera Pharmaceuticals, Inc. (NASDAQ:IDRA) Sees Large Increase in Short InterestIdera Pharmaceuticals, Inc. (NASDAQ:IDRA) was the recipient of a large increase in short interest in December. As of December 15th, there was short interest totalling 1,140,000 shares, an increase of 588.0% from the November 30th total of 165,700 shares. Based on an average trading volume of 1,010,000 shares, the short-interest ratio is currently 1.1 days. Approximately 2.8% of the shares of the company are short sold.January 3, 2022 | marketbeat.comIdera Shares Fall After Early Tilsotolimod Data, Seeks Collaborating Partners For TLR9 AgonistDecember 15, 2021 | msn.comIdera Pharmaceuticals Announces Tilsotolimod UpdatesDecember 14, 2021 | finance.yahoo.com5 Penny Stocks To Buy According To Analysts & Targets Up To 341%December 8, 2021 | chron.comIdera Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateNovember 8, 2021 | finance.yahoo.comIdera Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate UpdateAugust 9, 2021 | finance.yahoo.com Get Idera Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IDRA and its competitors with MarketBeat's FREE daily newsletter. Email Address IDRA Media Mentions By Week IDRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IDRA News Sentiment▼0.000.88▲Average Medical News Sentiment IDRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IDRA Articles This Week▼00▲IDRA Articles Average Week Get Idera Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IDRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Adaptive Biotechnologies News Today Mesoblast News Today Novavax News Today LENZ Therapeutics News Today Replimune Group News Today Vir Biotechnology News Today Iovance Biotherapeutics News Today Immatics News Today Anavex Life Sciences News Today Sana Biotechnology News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IDRA) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Idera Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Idera Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IDRA Stock Free IDRA Stock Alerts